Ventilator Correction: Philips Issues Correction for Trilogy Evo Platform Ventilators
Philips has issued a correction for Trilogy Evo platform ventilators due to potential malfunctions occurring when the devices are used in conjunction with specific nebulizers.
This affects healthcare facilities, respiratory therapists, and biomedical departments utilizing Philips Trilogy Evo platform ventilators, as well as the manufacturer's regulatory and quality divisions.
The source indicates a potential failure in intended function, which may lead to interruptions in ventilation therapy or unintended device behavior. From a regulatory perspective, this correction suggests a need for updated instructions for use (IFU) or compatibility matrices to mitigate risks associated with accessory-driven performance degradation. Compliance teams must likely monitor for similar cross-compatibility issues in the respiratory device portfolio.
Clinical engineering and QA teams should identify all Trilogy Evo units in inventory and verify compatibility with current nebulizer protocols. Regulatory teams should ensure that all internal training materials and labeling updates regarding nebulizer usage are implemented and documented for compliance purposes.
Philips Trilogy Evo Ventilators may not function as intended if used with certain nebulizers.
Open in openFDA / FDA.gov